Evidence map›Paper›PMID 33459805›Full record

ArticleOsteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA2021

Vertebral fractures are increased in rheumatoid arthritis despite recent therapeutic advances: a case-control study.

N Guañabens, J M Olmos, J L Hernández, D Cerdà, C Hidalgo Calleja, J A Martinez López, L Arboleya, F J Aguilar Del Rey, S Martinez Pardo, I Ros Vilamajó and 21 more

Registry-linked trialAbstract read
PubMed Publisher
In one paragraph

Article in Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT06092775 (Prevalence of Subclinical Vertebral Fractures in Rheumatoid Arthritis and Ankylosing Spondylitis in Egyptian Patients and Its Relation to Some Clinical Data), which is not on this map. Cited by 15 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed, 1 pooled it
3.4field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT06092775 unknown statusnot on this mapstarted 2023, after this paper: background citation

Prevalence of Subclinical Vertebral Fractures in Rheumatoid Arthritis and Ankylosing Spondylitis in Egyptian Patients and Its Relation to Some Clinical Data

TypeobservationalSponsorAssiut UniversityRan2023 to 2025Enrolled93ConditionsVertebral FractureArmsDEXA scan,X_ray
3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 1 synthesis or guideline pooled it, 24 citations in OpenAlex.

  1. Pooled it
  2. Bone Health in Rheumatoid Arthritis: An Update.Current rheumatology reports · 2026
    Review
  3. Article
  4. Article
  5. Review
  6. Review
  7. Observational
  8. Article
  9. Article
  10. Article
  11. Article
  12. Mechanisms of Systemic Osteoporosis in Rheumatoid Arthritis.International journal of molecular sciences · 2022
    Review
  13. Review
  14. Article
  15. Fracture in clinical studies of tofacitinib in rheumatoid arthritis.Therapeutic advances in musculoskeletal disease · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

31 authors at 20 institutions in 1 country.

N GuañabensDepartment of Rheumatology, Hospital Clínic, CIBERehd, IDIBAPS, University of Barcelona, Barcelona, Spain. nguanabens@ub.edu.ORCID https://orcid.org/0000-0002-7103-9530
J M OlmosDepartament of Internal Medicine, University Hospital Marqués de Valdecilla-IDIVAL, Universidad de Cantabria, Santander, Spain.
J L HernándezDepartament of Internal Medicine, University Hospital Marqués de Valdecilla-IDIVAL, Universidad de Cantabria, Santander, Spain.
D CerdàDepartment of Rheumatology, Hospital Moisès Broggi, Sant Joan Despí, University of Barcelona, Barcelona, Spain.
C Hidalgo CallejaDepartment of Rheumatology, University Hospital de Salamanca, Salamanca, Spain.
J A Martinez LópezDepartment of Rheumatology, University Hospital Fundación Jiménez Díaz, Madrid, Spain.
L ArboleyaDepartment of Rheumatology, University Hospital Central de Asturias, Oviedo, Spain.
F J Aguilar Del ReyDepartment of Rheumatology, University Hospital Virgen de la Victoria, Malaga, Spain.
S Martinez PardoDepartment of Rheumatology, University Hospital Mutua Terrassa, Barcelona, Spain.
I Ros VilamajóDepartment of Rheumatology, Hospital Son Llàtzer, Palma de Mallorca, Spain.
X Suris ArmanguéDepartment of Rheumatology, Hospital General de Granollers, Granollers, International University of Catalunya, Barcelona, Spain.
D GradosDepartment of Rheumatology, Hospital d'Igualada, Igualada, Barcelona, Spain.
C Beltrán AuderaDepartment of Rheumatology, University Hospital Miguel Servet, Zaragoza, Spain.
E Suero-RosarioDepartment of Rheumatology, Hospital General Mateu Orfila, Maó, Spain.
I Gómez GraciaDepartment of Rheumatology, University Hospital Reina Sofía, Cordoba, Spain.
A Salmoral ChamizoDepartment of Rheumatology, University Hospital Reina Sofía, Cordoba, Spain.
I Martín-EsteveDepartment of Rheumatology, Hospital General Mateu Orfila, Maó, Spain.
H FlorezDepartment of Rheumatology, Hospital Clínic, CIBERehd, IDIBAPS, University of Barcelona, Barcelona, Spain.
A NaranjoDepartment of Rheumatology, University Hospital de Gran Canaria Dr. Negrín, Las Palmas de Gran Canaria, Spain.
S CastañedaDepartment of Rheumatology, University Hospital La Princesa IIS-IP, Madrid, Spain.
S Ojeda BrunoDepartment of Rheumatology, University Hospital de Gran Canaria Dr. Negrín, Las Palmas de Gran Canaria, Spain.
S García CarazoDepartment of Rheumatology, University Hospital La Paz, Madrid, Spain.
A García VadilloDepartment of Rheumatology, University Hospital La Princesa IIS-IP, Madrid, Spain.
L López VivesDepartment of Rheumatology, Hospital Sant Rafael, Barcelona, Spain.
À Martínez-FerrerDepartment of Rheumatology, University Hospital Doctor Peset, Valencia, Spain.
H Borrell PañosDepartment of Rheumatology, Hospital Sant Rafael, Barcelona, Spain.
P Aguado AcínDepartment of Rheumatology, University Hospital La Paz, Madrid, Spain.
R Castellanos-MoreiraDepartment of Rheumatology, Hospital Clínic, CIBERehd, IDIBAPS, University of Barcelona, Barcelona, Spain.
C TebéBiostatistics Unit, Bellvitge Biomedical Research Institute (IDIBELL) L'Hospitalet de Llobregat, Barcelona, Spain.
C Gómez-VaqueroDepartment of Rheumatology, University Hospital de Bellvitge, L'Hospitalet de Llobregat, Barcelona, Spain.
OsteoResSer Working Group of the Spanish Society of Rheumatology
Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas · ESHospital General Mateu Orfila · ESHospital Universitario de Gran Canaria Doctor Negrín · ESHospital Universitario de La Princesa · ESHospital Universitario La Paz · ESHospital Universitario Reina Sofía · ESHospital Universitario San Rafael · ESUniversidad de Cantabria · ESBellvitge University Hospital · ESHospital Clínic de Barcelona · ESHospital Clínico Universitario Virgen de la Victoria · ESHospital de Sant Joan Despí Moisès Broggi · ESHospital d'Igualada · ESHospital General de Granollers · ESHospital Son Llatzer · ESHospital Universitario Central de Asturias · ESHospital Universitario Doctor Peset · ESHospital Universitario Fundación Jiménez Díaz · ESHospital Universitario Miguel Servet · ESInstitut d'Investigació Biomédica de Bellvitge · ES

Funding

Instituto de Salud Carlos III PI18/00762
6 · The paper itself

Abstract

Prevalence and risk factors of vertebral fractures in postmenopausal RA women were assessed in 323 patients and compared with 660 age-matched women. Of patients, 24.15% had at least one vertebral fracture vs.16.06% of controls. Age, glucocorticoids and falls were the main fracture risks. Vertebral fractures were associated with disease severity.

introductionThere is little quality data on the updated prevalence of fractures in rheumatoid arthritis (RA) that may have changed due to advances in the therapeutic strategy in recent years. This study was aimed at analysing the prevalence and risk factors of vertebral fractures in postmenopausal women with RA and comparing it with that of the general population.

methodsWe included 323 postmenopausal women diagnosed with RA from 19 Spanish Rheumatology Departments, randomly selected and recruited in 2018. Lateral radiographs of the thoracic and lumbar spine were obtained to evaluate morphometric vertebral fractures and the spinal deformity index. We analysed subject characteristics, factors related to RA, and fracture risk factors. The control group consisted of 660 age-matched Spanish postmenopausal women from the population-based Camargo cohort.

resultsSeventy-eight (24.15%) RA patients had at least one vertebral fracture. RA patients had increased fracture risk compared with controls (106 of 660, 16.06%) (p = 0.02). Logistic regression analysis showed that age (OR 2.17; 95% CI 1.27-4.00), glucocorticoids (OR 3.83; 95% CI 1.32-14.09) and falls (OR 3.57; 95% CI 1.91-6.86) were the independent predictors of vertebral fractures in RA patients. The subgroup with vertebral fractures had higher disease activity (DAS28: 3.15 vs. 2.78, p = 0.038) and disability (HAQ: 0.96 vs. 0.63, p = 0.049), as compared with those without vertebral fractures.

conclusionThe risk of vertebral fracture in RA is still high in recent years, when compared with the general population. The key determinants of fracture risk are age, glucocorticoids and falls. Patients with vertebral fractures have a more severe RA.

Indexed as

Arthritis, RheumatoidOsteoporosisOsteoporosis, PostmenopausalSpinal FracturesBone DensityCase-Control StudiesFemaleHumansLumbar VertebraeRisk FactorsOsteoporosisRheumatoid arthritisVertebral fractures

Identifiers

PMID33459805
OpenAlexW3121477570

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.